# An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

> **NCT00492479** · PHASE4 · TERMINATED · sponsor: **Innovative Medical**

## Conditions studied

- Skin Aging

## Interventions

- **DRUG:** Kinerase Pro+Therapy Line day repair, serum, night repair
- **DRUG:** Kinerase Pro+Therapy Line Ultra rich day repair
- **DRUG:** LubriDerm

## Key facts

- **NCT ID:** NCT00492479
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** — (—)
- **Last updated:** 2007-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492479, "An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00492479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*